Data / Form D filings / Neurock Pharmaceuticals Inc.
Neurock Pharmaceuticals Inc.: Form D filing
Neurock Pharmaceuticals Inc., a pharmaceuticals company in Princeton, NJ, filed a Form D with the SEC in 2024. The latest, on March 11, 2024, reports $10 million sold of a $10 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 302 CARNEGIE CENTER, SUITE 100, Princeton, NJ, 08540
- Phone
- (908) 926-3116
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2014918
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | New notice | $10,000,000 | $10,000,000 | 1 | Feb 29, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Haixing Wang | Executive Officer | |
| Qingxi Wang | Director | |
| Lei Cai | Executive Officer |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Mar 11, 2024 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Neurock Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.